Inventor · disambiguated record
Vinh X. Ngo
Also filed as: NGO VINH X · NGO VINH XUAN
28 granted patents·3 pending applications·110 citations·filing 2006–2024
95Inventor score
Top patents by PatentIndex Score
31 records- 0196US11117886B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Sep 14, 2021·15 cites·22 claims
- 0293US10696657B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 30, 2020·22 cites·21 claims
- 0392US7429669B2Therapeutic compoundsALLERGAN INC·Filed 2007·Granted Sep 30, 2008·15 cites·18 claims
- 0487US7592366B2Therapeutic compoundsALLERGAN INC·Filed 2007·Granted Sep 22, 2009·10 cites·19 claims
- 0587US7323591B2Substituted cyclopentanes or cyclopentanones as therapeutic agentsALLERGAN INC·Filed 2007·Granted Jan 29, 2008·9 cites·20 claims
- 0686US11760746B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 19, 2023·1 cites·14 claims
- 0786US7507817B2Prostaglandin prodrugsALLERGAN INC·Filed 2007·Granted Mar 24, 2009·8 cites·19 claims
- 0885US7405240B2Substituted cyclopentanes or cyclopentanones as therapeutic agentsALLERGAN INC·Filed 2008·Granted Jul 29, 2008·7 cites·24 claims
- 0984US7947732B2Therapeutic substituted chlorocyclopentanolsALLERGAN INC·Filed 2010·Granted May 24, 2011·7 cites·9 claims
- 1084US2025100999A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1183US7737140B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Jun 15, 2010·3 cites·18 claims
- 1282US7605178B2Therapeutic compoundsALLERGAN INC·Filed 2007·Granted Oct 20, 2009·4 cites·19 claims
- 1380US7662850B2Therapeutic substituted chlorocyclopentanolsALLERGAN INC·Filed 2008·Granted Feb 16, 2010·3 cites·16 claims
- 1478US7635716B2Substituted cyclopentanes or cyclopentanones as therapeutic agentsALLERGAN INC·Filed 2006·Granted Dec 22, 2009·3 cites·19 claims
- 1573US7998998B2Therapeutic substituted lactamsALLERGAN INC·Filed 2008·Granted Aug 16, 2011·1 cites·19 claims
- 1672US8252788B2Therapeutic compoundsOLD DAVID W·Filed 2009·Granted Aug 28, 2012·1 cites·14 claims
- 1770US7981887B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Jul 19, 2011·1 cites·17 claims
- 1865US8338637B2Therapeutic compoundsOLD DAVID W·Filed 2008·Granted Dec 25, 2012·0 cites·24 claims
- 1963US8003680B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Aug 23, 2011·0 cites·21 claims
- 2062US9591935B2Therapeutic substituted cyclopentanesOLD DAVID W·Filed 2008·Granted Mar 14, 2017·0 cites·21 claims
- 2161US7803798B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Sep 28, 2010·0 cites·10 claims
- 2256US9388153B2Secondary amines as therapeutic agentsALLERGAN INC·Filed 2014·Granted Jul 12, 2016·0 cites·24 claims
- 2355US2013005767A1Therapeutic compoundsALLERGAN INC·Filed 2012·Application pending·0 cites
- 2454US9540357B115-aryl prostaglandins as EP4 agonists, and methods of use thereofALLERGAN INC·Filed 2014·Granted Jan 10, 2017·0 cites·12 claims
- 2554US8569349B2Therapeutic compoundsOLD DAVID W·Filed 2009·Granted Oct 29, 2013·0 cites·11 claims
- 2654US8541603B2Substituted cyclopentanes or cyclopentanones as therapeutic agentsOLD DAVID W·Filed 2009·Granted Sep 24, 2013·0 cites·21 claims
- 2754US7803797B2Substituted arylcyclopentenes as therapeutic agentsALLERGAN INC·Filed 2009·Granted Sep 28, 2010·0 cites·11 claims
- 2853US9765065B2Therapeutic substituted cyclopentanesALLERGAN INC·Filed 2017·Granted Sep 19, 2017·0 cites·9 claims
- 2952US8039496B2Therapeutic compoundsALLERGAN INC·Filed 2008·Granted Oct 18, 2011·0 cites·16 claims
- 3051US8362054B2Therapeutic substituted lactamsALLERGAN INC·Filed 2008·Granted Jan 29, 2013·0 cites·19 claims
- 3147US2008015219A1Therapeutic compoundsALLERGAN INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vinh X. Ngo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →